Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28. Arthritis Rheumatol. 2023. PMID: 37635643
Evidence of transplacental passage of hydroxychloroquine in humans.
Costedoat-Chalumeau N, Amoura Z, Aymard G, Le TH, Wechsler B, Vauthier D, Dermer ME, Darbois Y, Piette JC. Costedoat-Chalumeau N, et al. Arthritis Rheum. 2002 Apr;46(4):1123-4. doi: 10.1002/art.10150. Arthritis Rheum. 2002. PMID: 11953993 Free article. No abstract available.
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
Costedoat-Chalumeau N, Amoura Z, Hulot JS, Hammoud HA, Aymard G, Cacoub P, Francès C, Wechsler B, Huong du LT, Ghillani P, Musset L, Lechat P, Piette JC. Costedoat-Chalumeau N, et al. Arthritis Rheum. 2006 Oct;54(10):3284-90. doi: 10.1002/art.22156. Arthritis Rheum. 2006. PMID: 17009263 Free article. Clinical Trial.
Hydroxychloroquine in systemic lupus erythematosus.
Costedoat-Chalumeau N, Amoura Z, Hulot JS, Lechat P, Piette JC. Costedoat-Chalumeau N, et al. Lancet. 2007 Apr 14;369(9569):1257-1258. doi: 10.1016/S0140-6736(07)60591-1. Lancet. 2007. PMID: 17434394 No abstract available.
[Hydroxychloroquine and systemic lupus: a reappraisal].
Costedoat-Chalumeau N, Leroux G, Amoura Z, Piette JC. Costedoat-Chalumeau N, et al. Rev Med Interne. 2008 Sep;29(9):735-7. doi: 10.1016/j.revmed.2007.05.031. Epub 2007 Jun 21. Rev Med Interne. 2008. PMID: 17618016 French.
361 results